Core Viewpoint - The company has released its 2025 semi-annual report, which includes details on financial performance, management decisions, and future plans, emphasizing the importance of transparency and compliance with regulatory requirements [5][8][70]. Company Overview - Company Name: Zhongzhu Medical Holdings Co., Ltd. [5] - Stock Code: 600568 [5] - The report is unaudited and aims to provide a comprehensive view of the company's operational results and financial status [2][8]. Financial Data - The report includes key financial data, although specific figures are not detailed in the provided text [4]. - There was no profit distribution or capital reserve transfer during the reporting period [3]. Important Matters - The company has not reported any significant changes in its operational situation during the reporting period [4]. - The board of directors and supervisory board have confirmed the authenticity and completeness of the report [1][5]. Board Meeting Decisions - The board meeting on August 27, 2025, approved the semi-annual report and its summary with unanimous consent [8][69]. - The board also approved a special report on the use of raised funds, which will be disclosed in detail [11][71]. - A proposal to change the accounting firm to Beijing Dehao International Accounting Firm was approved, with audit fees set at 800,000 RMB for financial audit and 300,000 RMB for internal control audit [12][76]. Fund Management - The report outlines the management and usage of raised funds, ensuring compliance with relevant regulations [16][18]. - As of June 30, 2025, the company has utilized 650 million RMB for working capital and various acquisition projects [23]. Upcoming Shareholder Meeting - The company will hold its first extraordinary general meeting of 2025 on September 15, 2025, to discuss the approved proposals [15][41].